(Q38311941)

2 September 2017

title

Growth hormone (GH)-independent dimerization of GH receptor by a leucine zipper results in constitutive activation (English)

1 reference

2 September 2017

Behncken SN

1

1 reference

2 September 2017

Billestrup N

2

1 reference

2 September 2017

Brown R

3

1 reference

2 September 2017

Amstrup J

4

1 reference

2 September 2017

Conway-Campbell B

5

1 reference

2 September 2017

Waters MJ

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

275

1 reference

2 September 2017

issue

22

1 reference

2 September 2017

page(s)

17000-17007

1 reference

Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Rational design of potent antagonists to the human growth hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Conformational changes required in the human growth hormone receptor for growth hormone signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Preferential heterodimer formation by isolated leucine zippers from fos and jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

A growth hormone agonist produced by targeted mutagenesis at binding site 1. Evidence that site 1 regulates bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Aspartate 171 is the major primate-specific determinant of human growth hormone. Engineering porcine growth hormone to activate the human receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Crystal structure of an antagonist mutant of human growth hormone, G120R, in complex with its receptor at 2.9 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Efficiency of signalling through cytokine receptors depends critically on receptor orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Functional replacement of cytokine receptor extracellular domains by leucine zippers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.22.17000

21 January 2018

Identifiers

DOI

10.1074/JBC.275.22.17000

1 reference

2 September 2017

1 reference